IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 217 filers reported holding IMMUNOGEN INC in Q2 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $211,424,711 | +380.9% | 13,322,288 | +471.8% | 4.16% | +401.4% |
Q2 2023 | $43,966,307 | -47.6% | 2,329,958 | -89.3% | 0.83% | -56.3% |
Q1 2023 | $83,919,199 | -22.6% | 21,853,958 | 0.0% | 1.90% | -13.6% |
Q4 2022 | $108,395,632 | +4.3% | 21,853,958 | +0.5% | 2.20% | -0.9% |
Q3 2022 | $103,924,000 | +6.2% | 21,741,458 | 0.0% | 2.22% | -15.0% |
Q2 2022 | $97,837,000 | -5.5% | 21,741,458 | 0.0% | 2.61% | +15.5% |
Q1 2022 | $103,489,000 | -31.1% | 21,741,458 | +7.4% | 2.26% | -14.7% |
Q4 2021 | $150,192,000 | +43.8% | 20,241,458 | +9.9% | 2.65% | +83.0% |
Q3 2021 | $104,427,000 | -14.0% | 18,417,458 | 0.0% | 1.45% | -25.7% |
Q2 2021 | $121,371,000 | -18.6% | 18,417,458 | 0.0% | 1.95% | -13.4% |
Q1 2021 | $149,181,000 | +25.6% | 18,417,458 | 0.0% | 2.25% | +35.4% |
Q4 2020 | $118,793,000 | +368.7% | 18,417,458 | +161.6% | 1.66% | +258.0% |
Q3 2020 | $25,346,000 | +43.9% | 7,040,485 | +36.3% | 0.46% | -16.5% |
Q1 2020 | $17,617,000 | – | 5,166,303 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |